Evidence mapPaperPMID 35546791Full record

ArticleDiabetes, obesity & metabolism2022

Liraglutide increases islet Ca

Karolina E Zaborska, Kelli L Jordan, Ariel S Thorson, Prasanna K Dadi, Charles M Schaub, Arya Y Nakhe, Matthew T Dickerson, Joshua C Lynch, Adam J Weiss, Jordyn R Dobson and 1 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Modulation ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. The MODY-associatedeLife · 2024
    Article
  7. Article
  8. Pancreatic δ Cells: An Overlooked Cell in Focus.Advances in anatomy, embryology, and cell biology · 2024
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Karolina E ZaborskaDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.ORCID 0000-0003-1218-5228
Kelli L JordanDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Ariel S ThorsonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Prasanna K DadiDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Charles M SchaubDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Arya Y NakheDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Matthew T DickersonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.ORCID 0000-0002-6187-3951
Joshua C LynchDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Adam J WeissDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Jordyn R DobsonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
David A JacobsonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.ORCID 0000-0003-1816-5375
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · VANDERBILT UNIVERSITY MEDICAL CENTER · 1995 to 2025
$32.7M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · VANDERBILT UNIVERSITY · 2001 to 2005
$5.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · VANDERBILT UNIVERSITY · 1985 to 2005
$5.1M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · VANDERBILT UNIVERSITY · 1988 to 2025
$4.0M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · 2024 to 2025
$3.2M
Initiative for Maximizing Student Development (IMSD) at VanderbiltT32GM139800 · NIGMS · VANDERBILT UNIVERSITY · 2022 to 2025
$2.1M
Vanderbilt Diabetes Research CenterP30DK020593 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$1.8M
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and DysfunctionR01DK129340 · VANDERBILT UNIVERSITY · 2025 to 2025
$450k
Integrated Training in Engineering and DiabetesT32DK101003 · VANDERBILT UNIVERSITY · 2025 to 2025
$393k
NCI NIH HHS P30 CA068485NIDDK NIH HHS P30 DK020593NIDDK NIH HHS R01 DK097392NIDDK NIH HHS R01 DK115620NIDDK NIH HHS R01 DK129340NIDDK NIH HHS T32 DK007563NIDDK NIH HHS T32 DK101003NIDDK NIH HHS U24 DK059637NIDDK NIH HHS UC4 DK098085NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM139800NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

aimTo determine whether hyperpolarization-activated cyclic nucleotide-gated (HCN) channels impact glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) modulation of islet Ca

methodsThe impact of liraglutide (GLP-1 analogue) on islet Ca

resultsLiraglutide increased β-cell Ca

conclusionThe data presented here show that liraglutide-induced stimulation of islet HCN channels augments Ca

Indexed as

Islets of LangerhansLiraglutideAnimalsGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsInsulinInsulin SecretionMiceGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsInsulinLiraglutide

Identifiers

PMID35546791
PMCPMC9843726
OpenAlexW4280498386

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.